Why Won't Europe Eat U.S. Meat?
By Martha Rosenberg
Food consumers seldom hear about the chemicals oestradiol-17, zeranol, trenbolone acetate and melengestrol acetate and the names are certainly not on meat labels. But those growth hormones, central to U.S. beef production, are the reason a lot of U.S. meat has been banned in Europe since 1989.
Melengestrol acetate, a synthetic progestin put in feed, is thirty times as active as natural progesterone, says the European Commission (EC). Trenbolone acetate, a synthetic androgen used as an ear implant, is several times more active than testosterone. (The ears and implants are discarded before entering the food supply say beef growers.)
Why does the European Commission ban U.S. meat? “There is an association between steroid hormones and certain cancers and an indication that meat consumption is possibly associated with increased risks of breast cancer and prostate cancer,” says the Commission's Scientific Committee on Veterinary Measures. “The highest rates of breast cancer are observed in North America, where hormone-treated meat consumption is highest in the world,” it says, adding that the same statistics apply to prostate cancer.
In fact, Kwang Hwa, Korea, has only seven new cases of breast cancer per 100,000 people, says the EC report, whereas non-Hispanic Caucasians in Los Angeles have 103 new cases per 100,000 people. The breast cancer rate also increases among immigrant groups when they move to the U.S., says the report, suggesting causes are not genetic but environmental.
Another growth drug used in U.S. beef, pork and turkey--yes turkey--is ractopamine an asthma-like drug called a beta agonist. Like growth hormones, ractopamine lets livestock operators produce more weight more quickly from their animals. Ractopamine was integrated into the food supply under reporters' and consumers' radar more than ten years ago. It became a favorite on U.S. farms when its ability to increase muscle by “repartitioning” nutrients and slowing protein degradation was discovered in a laboratory.
Unlike other veterinary drugs used in U.S. meat that are withdrawn before slaughter (or thrown away as ears) ractopamine isbegun in the days before slaughter and never withdrawn. It is given to cattle for their last 28 to 42 days, to pigs for their last 28 days, and to turkeys for their last seven to 14 days. Marketed as Paylean for pigs, as Optaflexx for cattle, and as Topmax for turkeys, ractopamine is not just banned in Europe, it is banned in 160 countries.
Public health officials and livestock specialists are increasingly questioning the drug's wide and often clandestine use. “Ractopamine usage benefits producers, but not consumers. It is bad for animal welfare and has some bad effects on humans,” said Donald Broom, a professor at the University of Cambridge’s department of veterinary medicine, at a forum on the topic in Taipei earlier this year.
In China, the Sichuan Pork Trade Chamber of Commerce reported that more than 1,700 people have been “poisoned” from eating Paylean-fed pigs since 1998 in 2007, it seized U.S. pork for its ractopamine residues.
Thanks to the effect of Big Meat's black hand on USDA and FDA policies, Americans have an almost unlimited supply of cheap meat for breakfast, lunch and dinner. Unfortunately it does a lot more for the meat industry's "health" than for food consumers'. END
Martha Rosenberg's acclaimed expose of Big Food, Born with a Junk Food Deficiency, is now available in bookstores, libraries, online and as an ebook in time for the holidays.
(Send your news to email@example.com, Foodconsumer.org is part of the Infoplus.com ™ news and information network)
- Fresh Frozen™ Vegetables Recalled
- Hospira Issues A Voluntary Nationwide Recall Of One Lot Of Bupivacaine HCl Injection Due To Potential Iron Oxide Particulate In Glass Vials
- Prominent Government Watchdog Asks Obama Administration to Remove Organic Leadership at USDA
- Organic Watchdog Grows Scientific Staff, Leadership Capacity The Cornucopia Institute Adds Staff, Announces Board Election Results
- Elevated cholesterol and triglycerides may increase the risk for prostate cancer recurrence